Probable medication-overuse headache: the effect of a 2-month drug-free period
- PMID: 16707727
- DOI: 10.1212/01.wnl.0000217914.30994.bd
Probable medication-overuse headache: the effect of a 2-month drug-free period
Abstract
Objective: To describe the emerging profile of headache frequency following a 2-month drug-free period in patients with medication overuse.
Methods: All patients treated and discharged from Danish Headache Center in 2002 and 2003 had prospectively filled out a diagnostic headache diary on a daily basis. For patients with probable medication-overuse headache (MOH), the authors determined headache frequencies before and after medication withdrawal from these prospective recordings.
Results: Among 1,326 patients, 337 had probable MOH. Two hundred sixteen patients who stayed medication-free for 2 months were eligible. Overall, 45% of the patients improved, 48% had no change, and 7% had more headaches. Median age was 48 years, and male/female ratio 1:2.7. The relative reduction in headache frequency varied considerably with a 67% median reduction in migraine, 0% in tension-type headache (TTH), and 37% in patients with both migraine and TTH (MT). Comparing the diagnostic groups, the relative reduction in frequency differed between migraine and TTH (p < 0.001) and between MT and TTH (p < 0.01). Triptan/ergot overusers improved the most (p < 0.0001). The difference between MT and TTH remained significant when triptan/ergot overuse was controlled (p < 0.05).
Conclusion: These data demonstrate the benefit of withdrawal in already established medication overuse and support the existence of medication-overuse headache as a clinical entity.
Comment in
-
Patient page. Chronic migraine and medication-overuse headache.Neurology. 2006 Jun 27;66(12):E43-4. doi: 10.1212/01.wnl.0000227588.24559.89. Neurology. 2006. PMID: 16801636 No abstract available.
-
Probable medication-overuse headache: the effect of a 2-month drug-free period.Neurology. 2007 Feb 13;68(7):536; author reply 536. doi: 10.1212/01.wnl.0000256979.23115.c4. Neurology. 2007. PMID: 17296926 No abstract available.
Similar articles
-
Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.Cephalalgia. 2009 Feb;29(2):214-20. doi: 10.1111/j.1468-2982.2008.01710.x. Epub 2008 Sep 24. Cephalalgia. 2009. PMID: 18823364
-
Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.Cephalalgia. 2006 Oct;26(10):1192-8. doi: 10.1111/j.1468-2982.2006.01190.x. Cephalalgia. 2006. PMID: 16961785
-
Patient page. Chronic migraine and medication-overuse headache.Neurology. 2006 Jun 27;66(12):E43-4. doi: 10.1212/01.wnl.0000227588.24559.89. Neurology. 2006. PMID: 16801636 No abstract available.
-
Chronic migraine: current concepts and ongoing treatments.Eur Rev Med Pharmacol Sci. 2011 Dec;15(12):1401-20. Eur Rev Med Pharmacol Sci. 2011. PMID: 22288302 Review.
-
Medication-overuse headache.Continuum (Minneap Minn). 2012 Aug;18(4):807-22. doi: 10.1212/01.CON.0000418644.32032.7b. Continuum (Minneap Minn). 2012. PMID: 22868543 Review.
Cited by
-
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial.JAMA Neurol. 2024 Sep 16;81(11):1140-9. doi: 10.1001/jamaneurol.2024.3043. Online ahead of print. JAMA Neurol. 2024. PMID: 39283627 Free PMC article.
-
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.Neurology. 2024 Jul 23;103(2):e209584. doi: 10.1212/WNL.0000000000209584. Epub 2024 Jun 26. Neurology. 2024. PMID: 38924724 Free PMC article. Clinical Trial.
-
Sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache.J Headache Pain. 2023 Nov 1;24(1):145. doi: 10.1186/s10194-023-01685-z. J Headache Pain. 2023. PMID: 37907887 Free PMC article.
-
Medication-overuse headache-a review of different treatment strategies.Front Pain Res (Lausanne). 2023 Oct 10;4:1103497. doi: 10.3389/fpain.2023.1103497. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37881687 Free PMC article. Review.
-
Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review.J Headache Pain. 2023 Aug 1;24(1):99. doi: 10.1186/s10194-023-01637-7. J Headache Pain. 2023. PMID: 37528353 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical